Japanese journal of clinical oncology
-
Jpn. J. Clin. Oncol. · Dec 2005
Randomized Controlled Trial Comparative StudyComparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
A clinical study of ramosetron was carried out to evaluate its efficacy in preventing both acute and delayed emesis in cisplatin-based chemotherapy by using a double-blind method with granisetron as the comparative drug. ⋯ Ramosetron is effective and safe for the control of acute and delayed emesis induced by cisplatin.